Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

By R. Kanner, N. Anthonisen, J. Connett. American Journal of Respiratory and Critical Care Medicine, 2001

653 citations recorded by the source corpus.

Subfields: Emergency Medical Services, Physiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/40752a4133ef54705baf7660d8e3f9672e9d1364

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Emergency Medical Services

1. P. Barnes

In Physiology

1. P. Barnes
2. P. Calverley

In Pulmonary and Respiratory Medicine

1. P. Barnes
2. R. Rodríguez-Roisín
3. C. Jenkins
4. Sonia Buist
5. Jan Zieliński
6. Yoshinosuke Fukuchi
7. S. Hurd
8. A. Anzueto

Citations in the corpus

• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, neutral): “Обострения ХОБЛ являются важными событиями в течении заболевания, так как они: • негативно влияют на качество жизни пациента [144, 391]; • ухудшают симптомы и функцию легких, причем воз" вращение к исходному уровню может занять несколь" ко недель [398]; • ускоряют темп снижения функции легких [399, ”
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, background): “d Accelerate the rate of decline of lung function (98, 99)”